A tsRNA-intertypic recombinant, v3/al-25, which has the 5' and 3' halves of the genome derived from the neurovirulent type 3 poliovirus strain 452/62 3D and the attenuated type 1 poliovirus strain LSc-gr3, respectively, was previously shown to cause severe paralytic poliomyelitis after intracerebral inoculation of monkeys. To ascertain whether the illness was caused by the recombinant itself or by temperature-resistant trRNA ÷ mutants that might have arisen in the inoculated monkeys, five independent virus strains have been isolated from the spinal cord of the diseased animals. While two of these isolates exhibited RNA ÷ and RNA -+ phenotypes, respectively, the other three strains retained the parental RNA-character. Except for the RNA + strain, the RNase T1 oligonucleotide maps of the genomes of all the isolates revealed only a minimal deviation from the parental pattern. These results were interpreted to mean that v3/al-25 is intrinsically neurovirulent despite the presence of a tsRNA-mutation(s) in the 3' half of its genome. Nevertheless, this mutation, or other peculiarities of the 3' half of the recombinant genome, may somewhat alleviate the pathogenicity of the virus. This notion was inferred from the fact that, when used in a relatively small dose (about 103 p.f.u.), v3/al-25 appeared to exhibit a lower level of neurovirulence compared to either the wild-type parent 452/62 3D, or a closely related intertypic recombinant having the genome 3' half derived from a neurovirulent trRNA -+ type 1 poliovirus strain. The problem of genetic determination of poliovirus neurovirulence and attenuation is briefly discussed.
INTRODUCTION
Recently, we devised a method for constructing poliovirus recombinants that derived two segments of the genome, each comprising roughly half of the RNA molecule, from parents belonging to different serotypes . Using the virulent and attenuated strains of poliovirus type 1 and type 3, we constructed several recombinants of this kind and assayed their neurovirulence by intracerebral inoculation of monkeys . Irrespective of the origin of the 3' half of the genome, the recombinants that inherited the 5' half from the neurovirulent parent were neurovirulent, whereas those that inherited a homologous segment from the attenuated parent were not. These observations could be most simply interpreted to mean that the major determinants of neurovirulence of the recombinants studied were located on the 5' halves of their genomes.
However, this interpretation, as already discussed , relied on several assumptions. Thus, we assumed that the illness was caused by the recombinants themselves, rather than by mutants that might have arisen (or been selected) in the central nervous system (CNS). Such an assumption was particularly important for interpreting the results obtained with 0000-6236 (~) 1985 SGM the neurovirulent recombinant v3/al-25. The 5' and 3" halves of its genome were derived from virulent type 3 (452/62 3D) and attenuated type 1 (LSc-gr3) strains, respectively, and the LScgr3-derived segment harboured a temperature-sensitive tsRNA-mutation(s) . The possibility existed that the disease was actually due to temperature-resistant trRNA ÷ mutants of v3/al-25, and not to the recombinant itself. To ascertain whether this was indeed the case, we isolated several strains from the spinal cord of monkeys that developed paralytic poliomyelitis after intracerebral infection with v3/a 1-25. The isolates were compared to v3/a 1-25 with respect to their ts and RNA phenotypes and by RNase T1 fingerprints of the genome. The results reported here strongly suggest that v3/al-25 is intrinsically neurovirulent despite the presence of a tsRNA-mutation(s) in the 3' half of its genome.
This does not mean, however, that the above mutation (or the entire 3' half of the v3/al-25 genome) is of no significance for the level of pathogenicity. In fact, we have noted previously that the incubation period preceding the onset of clinical signs of poliomyelitis was, on average, somewhat longer in monkeys inoculated with v3/al-25 than in monkeys inoculated with v3/v I-1 (the latter recombinant differed from the former by having the 3' half of the genome derived from the virulent strain Mgr . Proceeding from this observation, we tentatively suggested that the 3' half might modulate the level of neurovirulence although the latter was largely determined by the 5' half of the recombinant genome. This suggestion has now been verified by investigating the effect on poliomyelitis-inducing capacity of lower inoculation doses of the two recombinants. When a dose of about 103 p.f.u, was used, v3/al-25 exhibited a diminished level of virulence, as compared to v3/vl-1.
METHODS
Viruses. The origin and properties of poliovirus strains 452/62 3D, v3/vl-1 and v3/al-25 have been described previously Agol et al., 1984) . For the isolation of strains from the CNS of the virusinoculated monkeys, a I0~ suspension of the tissue of the spinal cord lumbar enlargement was prepared in physiological saline and inoculated, in a dose of 0.1 ml, into tubes with replicate monolayer cultures of monkey kidney cells. Incubation of the infected cultures was carried out at 33 °C, 37 °C, 38.5 °C and 40 °C, and those cultures which developed a cytopathic effect at the lowest temperature were chosen for further study. The isolated strains were passed twice at 36 °C in HeLa cells before use.
Neurovirulence assay. Viral neurovirulence was tested by intracerebral inoculation of Cercopithecus aethiops monkeys as described previously . To evaluate the severity of histological damage, two indices, S (spread) and LS (lesion score), were used. Index S represented the number of levels of the CNS with specific histological lesions, the maximal value for a single monkey being 29 (the number of levels investigated). Index LS was calculated as the average score of histological lesions (including zero scores) in one hemisection, the maximum value being 4. It should be noted that evaluation of the lesions in the CNS of the virus-inoculated animals in the present and previous studies was done by different investigators; the absolute values of the LS indices in these two reports should not, therefore, be directly compared.
Determination of viral RNA synthesis. Replicate monolayer cultures of HeLa cells (4 x 105 to 5 x 105 ceils) were infected at an input multiplicity of about 100 p.f.u./cell and, after I h adsorption at room temperature and removal of the unadsorbed virus, they were transferred to either 36.5 °C or 39.5 °C. At appropriate time intervals, 1 ~tg/ml actinomycin D (Calbiochem) was added, followed after 15 rain by a mixture of 3H-labelled precursors (uridine, adenosine and cytidine with specific activities of 20 to 30 Ci/mmol; 2.5 to 5 ~tCi/ml). The cultures were frozen 15 min later, and incorporation of label into TCA-insoluble material was determined. To evaluate the background actinomycin D-resistant nucleoside incorporation, control cultures were infected with a guanidine-sensitive poliovirus strain in the presence of I00 vtg/ml guanidine-HCl and were treated similarly to the above samples.
Oligonucleotide mapping of the viral genomes. RNA isolated from purified virus preparations was treated with RNase T1, the resultant oligonucleotides were 5'-labelled using [~-32p]ATP and bacteriophage T4 polynucleotide kinase and subjected to two-dimensional electrophoresis as described previously . It should be pointed out that the relative intensity of some spots varied somewhat from experiment to experiment, but the pattern itself was highly reproducible. moderate to severe lesions at nearly all the CNS levels studied. Tetraplegy; moderate to severe lesions at nearly all the CNS levels studied.
RESULTS

Virus isolation from the central nervous system of diseased monkeys
* Monkeys 4973 and 4846 were from the experiment presented in Table 2 of this report, whereas monkeys 4953, 4956 and 4964 were from the experiment described in Table 4 of our previous study . 
Some phenotypic properties of the isolates
The ratio of efficiency of plaquing at 40 °C and 33 °C in HeLa cells was less than 10 -s for all of the isolates (as well as for the parental strain v3/al-25), except M4964, which formed approximately the same number of plaques at either temperature (data not shown). Thus, the latter strain should be classified as tr (or ts +) whereas the remaining ones exhibited a ts phenotype.
The ability of the isolates to synthesize virus-specific RNA at 39.5 °C was studied. The results shown in Fig. 1 demonstrate that three strains, i.e. M4953, M4973 and M4846, like their parent v3/al-25, failed to synthesize appreciable amounts of viral RNA at this temperature and all should be assigned an RNA-phenotype. In this respect, these strains resembled LSc-gr3, the donor of the 3' half of their genomes (see Agol et al., 1984 
Fingerprinting of the viral genomes
The RNase TI oligonucleotide maps of the genomes of the five isolates as well as of their parental virus v3/a 1-25 are shown in Fig. 2 . It is seen that the maps of the isolates resembled very closely that of their parent. In fact, the fingerprints of four out of five isolates revealed only a single spot common to all of them in addition to an apparently complete set of spots characteristic of the fingerprint of v3/a 1-25. Strain M4964 was an exception: it exhibited a more deviant pattern, with several parental oligonucleotides missing and new oligonucleotides present (Fig. 2) .
Neurovirulence studies Our previous observations allowed us to consider the possibility that the 3' half of the genome might modulate to some extent the expression of the pathogenicity of the recombinants . In order to evaluate this modulating effect, we now compared the neurovirulence of v3/al-25 and v3/vl-1 (two recombinants which shared the 5' segment of the RNA molecule but inherited its 3' segment from attenuated and virulent parents, respectively) using lower inoculation doses than previously . As shown in Table 2 , v3/v-l, like its type 3 virulent parent 452/62 3D, expressed almost the same high level of pathogenicity irrespective of the dose inoculated (in the range of 103 to 105 p.f.u.). On the other hand, v3/al-25, being also highly virulent at 3 x 105 p.f.u., exerted a markedly milder effect at 3 x 103 p.f.u. At this latter dose, v3/al-25 exhibited a reduced level of neurovirulence, as compared to v3/vl-l, in terms of both the proportion of animals paralysed and the severity of morphological injuries in the central nervous system. DISCUSSION Two points were addressed in this study. The first concerned the properties of the viruses isolated from the CNS of monkeys paralysed after inoculation with the intertypic poliovirus recombinant v3/al-25. In particular, we were interested to learn whether the isolates retained the tsRNA-phenotype of the parental virus. A positive answer was obtained for three of the five isolates studied. This fact supports our earlier contention that the existence of tsRNAmutation(s) is by itself not sufficient to endow the virus with a non-virulent phenotype. Furthermore, all the three tsRNA-isolates (M4846, M4953 and M4973) appeared to have undergone only a minimal genetic deviation from their parent. The remote possibility remains that the changes in the genomes of the isolated viruses detected by fingerprinting (or even some undetected mutations) are essential for neurovirulence. We consider it more likely, however, that v3/al-25 itself is intrinsically neurovirulent.
At the same time, our results suggest that the loss of the tsRNA-character may confer a selective advantage on the virus with regard to its ability to grow in the CNS. Thus, several clones isolated from monkey no. 4964 all exhibited the tr phenotype (unpublished observations). It seems possible, therefore, that the paralytic poliomyelitis in some monkeys inoculated with v3/al-25 might have been caused by mutants which could have evolved prior to or during the multiplication of the virus in the CNS. We would like to emphasize, however, that emergence of such mutants does not appear to be a precondition for the manifestation of the disease.
The second point of this study concerned the possible contribution of the 3' half of the viral genome to neurovirulence. The results showed that this part of the attenuated poliovirus type 1 genome when recombined with the 5' half of the virulent type 3 genome, may alleviate to some extent the virulence of the recombinant. It is tempting to propose that this modulating effect is caused by the tsRNA-mutation discussed above, present in the 3' half of the recombinant RNA molecule.
Thus, the aggregate results obtained to date with intertypic (type 3 x type 1) poliovirus recombinants support the notion that the 5' half of their genome contributes to neurovirulence (attenuation) to a significantly greater extent than the 3' half does.
When considering the genetic determination of poliovirus neurovirulence in more general terms, one may envisage two models. The first postulates the existence of a single (or a few) property(ies) of the attenuated virus that specifically deprives it of the ability either to infect, multiply in, and injure the target neural cells, or spread through the CNS. Virus strains possessing this property will be attenuated irrespective of their reproductive capacity in other host cells. Obligatory changes of this specific property are needed for the virus to be neurovirulent. In the framework of this model, the genetic locus responsible for this critical property may be regarded as the major genetic determinant of attenuation (neurovirulence). Needless to say, alterations in other regions of the genome that non-specifically either enhance or diminish the reproductive capacity of virus strains may modulate the level of their pathogenicity. The second model does not invoke any specific properties of poliovirus other than those involved in its general reproductive capacity in sensitive cells of primate origin. Here, attenuated strains differ from neurovirulent ones merely in the diminished yield of infectious progeny and, possibly, reduced cytopathogenicity. For example, introduction of ts mutations into any region of the vrial genome will be expected to result in an equal level of attenuation, provided these mutations equally restrict the virus growth at the body temperature of the infected organism.
Data on the neurovirulence of poliovirus recombinants accumulated so far do not allow a clear discrimination between these models. Nevertheless, the greater contribution of the 5' half of the genome to the neurovirulence of the recombinants studied, as well as the relatively minor effect of the strong tsRNA-mutation situated in the 3' half, suggest that a model implicating specific viral properties in neurovirulence deserves serious attention. It is also appropriate to note that among numerous mutations distributed over nearly the entire genome, of foot-and-mouth disease virus, only a ts mutation in the capsid protein-coding region (probably a region coding for polypeptide VP3) appeared to abolish the neurovirulent properties of the virus (McCahon et al., 1981) . On the other hand, a comparison of the partial nucleotide sequences of the genome of a virulent type 3 poliovirus, its attenuated derivative and a virulent revertant of the latter failed to reveal any changes in the amino acid sequence of the capsid polypeptides that could unambiguously be linked to variation in neurovirulence (Stanway et al., 1983) . It should be remarked that major determinants of neurovirulence, if indeed located on the 5' half of the poliovirus genome, need not necessarily be related to virus-specific proteins; this segment of the RNA molecule also encompasses a long untranslated region of potential regulatory importance (Kitamura et al., 1981; Racaniello & Baltimore, 1981) .
